Use of a Novel Electronic Auto-Notification Process to Manage Transitions of Care in Patients With Rheumatic Disease Receiving Disease-Modifying Antirheumatic Drug Therapy.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
11 2022
Historique:
revised: 05 05 2021
received: 21 07 2020
accepted: 27 05 2021
pubmed: 1 6 2021
medline: 26 10 2022
entrez: 31 5 2021
Statut: ppublish

Résumé

To integrate an auto-notification system into clinical workflow, so timely communication of sentinel events (elective surgery, hospital admission, or emergency room [ER] visit) in immunosuppressed patients with rheumatic disease happened by design. We developed an algorithm that triggered auto-notification within the electronic medical record to rheumatology when a patient experienced a sentinel event. A telephone encounter was created that included event type, baseline therapy, and event date. This was forwarded to the rheumatologist, who recorded guideline-driven recommendations and returned it to nursing. Instructions were included to communicate recommendations to the patient, inpatient rheumatology team, or other clinician. This was studied over 4 months at a multispecialty medical practice in Central Pennsylvania. Primary outcomes were percentage of total notifications, notifications by sentinel event type where a change in care plan was recommended, as well as percentage of time where rheumatologists were notified of sentinel events compared to prior to the intervention. The secondary outcome was staff work effort. Two hundred forty notifications were received (57% for elective surgeries, 39% for ER visits, and 4% for admissions). The need for change in care plan was only 17% for ER visits but was 25% for hospital admissions and 44% for elective surgeries. The percentage of time that rheumatologists were notified of events increased from 57.6% to 100%. The average number of messages received per week was 2.2, requiring a weekly average of 13 minutes of work per physician. We developed an easy, well-received process that hardwires rheumatologist notification sentinel events to facilitate timely care.

Identifiants

pubmed: 34057303
doi: 10.1002/acr.24721
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1903-1908

Informations de copyright

© 2021 American College of Rheumatology.

Références

Eriksson JK, Johansson K, Askling J, Neovius M. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? Ann Rheum Dis 2015;74:648-54.
Michet CJ, Strobova K, Achenbach S, Crowson CS, Matteson EL. Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota. Mayo Clin Proc 2015;90:176-83.
Louie GH, Ward MM. Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis 2010;69:868-71.
Härle P, Straub RH, Fleck M. Perioperative management of immunosuppression in rheumatic diseases: what to do? Rheumatol Int 2010;30:999-1004.
Jani M, Barton A, Hyrich K. Predication of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification? Curr Opin Rheumatol 2019;31:285-92.
Henry MW, Brause BD, Miller AO. Infection and perioperative orthopedic care. In: MacKenzie C, Cornell C, Memtsoudis S, editors. Perioperative care of the orthopedic patient. Cham: Springer; 2020.
Goh L, Jewell T, Laversuch C, Samanta A. Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence. Rheumatol Int 2012;32:5-13.
Stundner O, Chiu YL, Sun X, Goodman SM, Russell LA, Calloway JJ, et al. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin Exp Rheumatol 2013;31:889-95.
Weiss RJ, Garellick G, Karrholm J, Hailer NP. Total hip arthroplasty in 6690 patients with inflammatory arthritis: effect of medical comorbidities and age on early mortality. J Rheumatol 2016;43:1320-7.
Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:254-63.
Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012;94:794-800.
Singh JA, Inacio MC, Namba RS, Paxton EW. Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: a cohort study. Arthritis Care Res (Hoboken) 2015;67:718-24.
Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol 2017;69:1538-51.
Tacang A, Downey C, Denio A, Newman E, Schroeder LL. Communication between inpatient and outpatient specialty clinicians: developing a better understanding of patients with rheumatoid arthritis who are admitted to the hospital [abstract]. Arthritis Rheumatol 2017;69 Suppl 10. URL: https://acrabstracts.org/abstract/communication-between-inpatient-and-outpatient-specialty-clinicians-developing-a-better-understanding-of-patients-with-rheumatoid-arthritis-who-are-admitted-to-the-hospital/.

Auteurs

Megan Bielawski (M)

Crystal Arthritis Center, Akron, Ohio.

Eric Newman (E)

Geisinger Medical Center, Danville, Pennsylvania.

Lisa L Schroeder (LL)

Geisinger Medical Center, Danville, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH